South Korean Drug Exports Up 16.7%

2 April 1995

Pharmaceutical exports from South Korea increased by 16.7% in 1994 compared with 1993 to their highest-ever level of $411 million, reports Pharma Japan, although sales of finished drug products declined.

The biggest contribution to the overall increase was in exports of bulk pharmaceuticals, which advanced 23.5% to $304.3 million, while overseas sales of cosmetics increased 36.7% to $25 million. However, exports of finished products declined 2.4% to a total of $63.8 million, while traditional medicines were down 20.4% to $14.7 million and exports of sanitary supplies fell 9.1% to $3.3 million.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight